Associated Papers
A literature review and database of how the primary KIT/PDGFRA variant of a gastrointestinal stromal tumour predicts for sensitivity to imatinib.
Wong NACS et al.
Cancer Genetics, 2022
Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon.
Incorvaia L et al.
Cancers, 2021
A quality control program for mutation detection in KIT and PDGFRA in gastrointestinal stromal tumours.
Hostein I et al.
Journal of Gastroenterology, 2011
Select a paper to view details